Calcitonin gene-related peptide and cyclic adenosine 5′- monophosphate/protein kinase a pathway promote IL-9 production in Th9 differentiation process

Journal of Immunology

Volumn 190, Issue 8, 2013, Pages 4046-4055

  Mikami, Norihisa ^a   Miyagi, Yayoi ^a   Sueda, Kaori ^a   Takatsuji, Miku ^a   Fukada, So Ichiro ^a   Yamamoto, Hiroshi ^a   Tsujikawa, Kazutake ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 9; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR PU 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INACTIVATION; EX VIVO STUDY; HELPER CELL; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; TH9 CELL;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CELL DIFFERENTIATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLYCOGEN SYNTHASE KINASE 3; INTERLEUKIN-1; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84876002267     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203102     Document Type: Article

References (56)

1. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
2. Zheng, W., and R. A. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596.
3. + T helper cells. Cell 126: 1121-1133.
4. Hori, S., and S. Sakaguchi. 2004. Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect. 6: 745-751.
5. Veldhoen, M., C. Uyttenhove, J. van Snick, H. Helmby, A. Westendorf, J. Buer, B. Martin, C. Wilhelm, and B. Stockinger. 2008. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an inter-leukin 9-producing subset. Nat. Immunol. 9: 1341-1346.
6. (-) effector T cells. Nat. Immunol. 9: 1347-1355.
7. Demoulin, J. B., and J.-C. Renauld. 1998. Interleukin 9 and its receptor: an overview of structure and function. Int. Rev. Immunol. 16: 345-364.
8. Dong, Q., J. Louahed, A. Vink, C. D. Sullivan, C. J. Messler, Y. Zhou, A. Haczku, F. Huaux, M. Arras, K. J. Holroyd, et al. 1999. IL-9 induces che-mokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur. J. Immunol. 29: 2130-2139.
9. Renauld, J.-C., F. Houssiau, J. Louahed, A. Vink, J. Van Snick, and C. Uyttenhove. 1993. Interleukin-9. Adv. Immunol. 54: 79-97.
10. Van Snick, J., A. Goethals, J.-C. Renauld, E. Van Roost, C. Uyttenhove, M. R. Rubira, R. L. Moritz, and R. J. Simpson. 1989. Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J. Exp. Med. 169: 363-368.
11. Townsend, J. M., G. P. Fallon, J. D. Matthews, P. Smith, E. H. Jolin, and N. A. McKenzie. 2000. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13: 573-583.
12. Temann, U. A., P. Ray, and R. A. Flavell. 2002. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J. Clin. Invest. 109: 29-39.
13. Corren, J. 2011. Cytokine inhibition in severe asthma: current knowledge and future directions. Curr. Opin. Pulm. Med. 17: 29-33.
14. Chang, H. C., S. Sehra, R. Goswami, W. Yao, Q. Yu, G. L. Stritesky, R. Jabeen, C. McKinley, A. N. Ahyi, L. Han, et al. 2010. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11: 527-534.
15. Angkasekwinai, P., S. H. Chang, M. Thapa, H. Watarai, and C. Dong. 2010. Regulation of IL-9 expression by IL-25 signaling. Nat. Immunol. 11: 250-256.
16. Jash, A., A. Sahoo, G. C. Kim, C. S. Chae, J. S. Hwang, J. E. Kim, and S. H. Im. 2012. Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chro-matin modification facilitates nuclear factor-κB (NF-κB)- mediated interleukin-9 (IL-9) transactivation. J. Biol. Chem. 287: 15445-15457.
17. Staudt, V., E. Bothur, M. Klein, K. Lingnau, S. Reuter, N. Grebe, B. Gerlitzki, M. Hoffmann, A. Ulges, C. Taube, et al. 2010. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33: 192-202.
18. Eigler, A., B. Siegmund, U. Emmerich, K. H. Baumann, G. Hartmann, and S. Endres. 1998. Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production. J. Leukoc. Biol. 63: 101-107.
19. Blomhoff, H. K., E. B. Smeland, K. Beiske, R. Blomhoff, E. Ruud, T. Bjøro, S. Pfeifer-Ohlsson, R. Watt, S. Funderud, T. Godal, and R. Ohlsson. 1987. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. J. Cell. Physiol. 131: 426-433.
20. Myklebust, J. H., D. Josefsen, H. K. Blomhoff, F. O. Levy, S. Naderi, J. C. Reed, and E. B. Smeland. 1999. Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. J. Cell. Physiol. 180: 71-80.
21. Kaneko, T., R. Alvarez, I. F. Ueki, and J. A. Nadel. 1995. Elevated intra-cellular cyclic AMP inhibits chemotaxis in human eosinophils. Cell. Signal. 7: 527-534.
22. Aronoff, D. M., C. Canetti, and M. Peters-Golden. 2004. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J. Immunol. 173: 559-565.
23. Rand, C. S., R. J. Wright, M. D. Cabana, M. B. Foggs, J. S. Halterman, L. Olson, W. M. Vollmer, S. R. Wilson, and V. Taggart. 2012. Mediators of asthma outcomes. J. Allergy Clin. Immunol. 129: S136-S141.
24. Xu, H., M. Zhao, and X. Wang. 1999. [Changes of calcitonin gene-related peptide content in induced sputum from patients with COPD and asthma]. Chinese Journal of Tuberculosis and Respiratory Diseases 22: 558-561.
25. Cardell, L. O., R. Uddman, and L. Edvinsson. 1994. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma. Eur. Respir. J. 7: 2169-2173.
26. Kawamura, N., H. Tamura, S. Obana, M. Wenner, T. Ishikawa, A. Nakata, and H. Yamamoto. 1998. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 5: 9-15.
27. Tokoyoda, K., K. Tsujikawa, H. Matsushita, Y. Ono, T. Hayashi, Y. Harada, R. Abe, M. Kubo, and H. Yamamoto. 2004. Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells. Int. Immunol. 16: 643-653.
28. Mikami, N., K. Watanabe, N. Hashimoto, Y. Miyagi, K. Sueda, S. Fukada, H. Yamamoto, and K. Tsujikawa. 2012. Calcitonin gene-related peptide enhances experimental autoimmune encephalomyelitis by promoting Th17-cell functions. Int. Immunol. 24: 681-691.
29. Boudard, F., and M. Bastide. 1991. Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis. J. Neurosci. Res. 29: 29-41.
30. Ding, W., J. A. Wagner, and R. D. Granstein. 2007. CGRP, PACAP, and VIP modulate Langerhans cell function by inhibiting NF-kappaB activation. J. Invest. Dermatol. 127: 2357-2367.
31. McGillis, J. P., S. Humphreys, V. Rangnekar, and J. Ciallella. 1993. Modulation of B lymphocyte differentiation by calcitonin gene-related peptide (CGRP). I. Characterization of high-affinity CGRP receptors on murine 70Z/3 cells. Cell. Immunol. 150: 391-404.
32. Tsujikawa, K., K. Yayama, T. Hayashi, H. Matsushita, T. Yamaguchi, T. Shigeno, Y. Ogitani, M. Hirayama, T. Kato, S. Fukada, et al. 2007. Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc. Natl. Acad. Sci. USA 104: 16702-16707.
33. Mikami, N., H. Matsushita, T. Kato, R. Kawasaki, T. Sawazaki, T. Kishimoto, Y. Ogitani, K. Watanabe, Y. Miyagi, K. Sueda, et al. 2011. Calcitonin gene-related peptide is an important regulator of cutaneous immunity: effect on dendritic cell and T cell functions. J. Immunol. 186: 6886-6893.
34. Yoshikawa, R., N. Mikami, I. Otani, T. Kishimoto, S. Nishioka, N. Hashimoto, Y. Miyagi, Y. Takuma, K. Sueda, S. Fukada, et al. 2011. Suppression of ovalbumin-induced allergic diarrhea by diminished intestinal peristalsis in RAMP1-deficient mice. Biochem. Biophys. Res. Commun. 410: 389-393.
35. Aoki-Nagase, T., T. Nagase, Y. Oh-Hashi, T. Shindo, Y. Kurihara, Y. Yamaguchi, H. Yamamoto, T. Tomita, E. Ohga, R. Nagai, et al. 2002. Attenuation of antigen-induced airway hyperresponsiveness in CGRP-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: L963-L970.
36. Vang, T., K. M. Torgersen, V. Sundvold, M. Saxena, F. O. Levy, B. S. Skålhegg, V. Hansson, T. Mustelin, and K. Taskén. 2001. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J. Exp. Med. 193: 497-507.
37. de Rooij, J., F. J. Zwartkruis, M. H. Verheijen, R. H. Cool, S. M. Nijman, A. Wittinghofer, and J. L. Bos. 1998. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396: 474-477.
38. Mikami, N., S. Fukada, H. Yamamoto, and K. Tsujikawa. 2012. Neuronal derivative mediators that regulate cutaneous inflammations. Crit. Rev. Immunol. 32: 307-320.
39. Beals, C. R., C. M. Sheridan, C. W. Turck, P. Gardner, and G. R. Crabtree. 1997. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275: 1930-1934.
40. Fang, X., S. X. Yu, Y. Lu, R. C. Bast, Jr., J. R. Woodgett, and G. B. Mills. 2000. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein ki-nase A. Proc. Natl. Acad. Sci. USA 97: 11960-11965.
41. Naot, D., and J. Cornish. 2008. The role of peptides and receptors of the cal-citonin family in the regulation of bone metabolism. Bone 43: 813-818.
42. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
43. Grünig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263.
44. Munitz, A., E. B. Brandt, M. Mingler, F. D. Finkelman, and M. E. Rothenberg. 2008. Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis. Proc. Natl. Acad. Sci. USA 105: 7240-7245.
45. Temann, U. A., Y. Laouar, E. E. Eynon, R. Homer, and R. A. Flavell. 2007. IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int. Immunol. 19: 1-10.
46. Hültner, L., S. Kölsch, M. Stassen, U. Kaspers, J. P. Kremer, R. Mailhammer, J. Moeller, H. Broszeit, and E. Schmitt. 2000. In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J. Immunol. 164: 5556-5563.
47. Gounni, A. S., E. Nutku, L. Koussih, F. Aris, J. Louahed, R. C. Levitt, N. C. Nicolaides, and Q. Hamid. 2000. IL-9 expression by human eosinophils: regulation by IL-1beta and TNF-alpha. J. Allergy Clin. Immunol. 106: 460-466.
48. Stassen, M., C. Müller, M. Arnold, L. Hültner, S. Klein-Hessling, C. Neudörfl, T. Reineke, E. Serfling, and E. Schmitt. 2001. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J. Immunol. 166: 4391-4398.
49. Wong, M. T., J. J. Ye, M. N. Alonso, A. Landrigan, R. K. Cheung, E. Engleman, and P. J. Utz. 2010. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol. Cell Biol. 88: 624-631.
50. Zhu, Y. X., L. Y. Kang, W. Luo, C. C. Li, L. Yang, and Y. C. Yang. 1996. Multiple transcription factors are required for activation of human interleukin 9 gene in T cells. J. Biol. Chem. 271: 15815-15822.
51. Scheinman, E. J., and O. Avni. 2009. Transcriptional regulation of GATA3 in T helper cells by the integrated activities of transcription factors downstream of the interleukin-4 receptor and T cell receptor. J. Biol. Chem. 284: 3037-3048.
52. Neal, J. W., and N. A. Clipstone. 2001. Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc. J. Biol. Chem. 276: 3666-3673.
53. Stambolic, V., and J. R. Woodgett. 1994. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem. J. 303: 701-704.
54. Elekes, K., K. Sandor, A. Moricz, L. Kereskai, A. Kemeny, E. Szoke, A. Perkecz, D. Reglodi, H. Hashimoto, E. Pinter, et al. 2011. Pituitary adenylate cyclase-activating polypeptide plays an anti-inflammatory role in endotoxin-induced airway inflammation: in vivo study with gene-deleted mice. Peptides 32: 1439-1446.
55. Szema, A. M., S. A. Hamidi, S. Lyubsky, K. G. Dickman, S. Mathew, T. Abdel-Razek, J. J. Chen, J. A. Waschek, and S. I. Said. 2006. Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L880-L886.
56. Kinhult, J., R. Uddman, M. Laan, A. Lindén, and L. O. Cardell. 2001. Pituitary adenylate cyclase-activating peptide inhibits neutrophil chemotaxis. Peptides 22: 2151-2154.